Atlas Trials

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

Clinical trial NCT05220917 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05220917
Sponsor
Brigham and Women's Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Cardiovascular EventsType2 DiabetesRenal Disease
Start date
2021-08-01
Primary completion
2026-05-31
Enrollment
781430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.